Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine - Wikidata - awgldk - TriplyDB

Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine

Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine

http://www.wikidata.org/entity/Q24629949

about

Technical Development of a New Meningococcal Conjugate Vaccine Incidence, carriage and case-carrier ratios for meningococcal meningitis in the African meningitis belt: a systematic review and meta-analysis Household crowding, social mixing patterns and respiratory symptoms in seven countries of the African meningitis belt An epidemiological review of changes in meningococcal biology during the last 100 years Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis.Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM).Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso.Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.Seasonality of meningitis in Africa and climate forcing: aerosols stand out.Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008 Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt.Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine.Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria.Methods for identifying Neisseria meningitidis carriers: a multi-center study in the African meningitis belt.Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013-14 Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive disease Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity.Characterization of Carriage Isolates of Neisseria meningitides in the Adolescents and Young Adults Population of Bogota (Colombia)The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine.Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine Public Health Impact After the Introduction of PsA-TT: The First 4 Years Carriage of Neisseria lactamica in 1- to 29-year-old people in Burkina Faso: epidemiology and molecular characterization.Pharyngeal carriage of Neisseria species in the African meningitis belt.The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012.Meningococcal carriage in the African meningitis belt.New frontiers in meningococcal vaccines.Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region.Advances with vaccination against Neisseria meningitidis.Serogroup A meningococcal conjugate vaccines in Africa.Parameter and state estimation in a Neisseria meningitidis model: A study case of Niger.Modelling meningococcal meningitis in the African meningitis belt.The endgame for serogroup a meningococcal disease in Africa?Meningococcal carriage within households in the African meningitis belt: A longitudinal pilot study.Increase of Neisseria meningitidis W:cc11 invasive disease in Chile has no correlation with carriage in adolescents.Vaccination strategies for the prevention of meningococcal disease.

P2860

Q26778279-DB5BD955-4583-4AEA-8C68-3E1A07389706 Q26825352-816A7A9E-37E9-4ECF-9EF7-86CB25878A22 Q33837062-E29A3121-1A94-4A43-9376-AB256B7D434D Q33850814-92090C60-3146-48F0-9DDD-5449C2A6492D Q33988997-1FA95C6D-3563-465D-BA6E-48922C609D08 Q34267478-A673B2DD-B7BE-45CD-BF2E-11418254577D Q34346578-20187500-CFC2-4755-BA6E-B9BB3B587B26 Q34363122-CC0AC475-70A2-44D7-8F15-9D2AF90DFC32 Q34430626-45A6E1F2-94A9-406B-A165-823665AA2AD7 Q34504030-2868CC9D-97C8-48D1-803E-CCD82B6F4037 Q34606343-745703C1-A901-443C-AE0C-C443FF8F1CEB Q34707962-03848D60-A41F-4571-AE61-4F4E04D20893 Q34721179-062A6616-3C1E-497C-9DEB-FC6FB46896BC Q34892719-5A48BDAC-7BE2-470E-8F74-27ACA0216E17 Q35029246-ADB46930-FC60-43AB-BDB5-9B0116055604 Q35032544-09CD43BF-B023-4836-B86D-2E6975ED5699 Q35064842-710B4A98-7434-4506-AF49-A19EB9B4AF7E Q35187182-00D61CE5-D11B-4567-8299-3CEF0447174C Q35639159-F5AA9A6C-5E7A-4EB9-ADED-0FB43509546E Q35760344-6678C4D1-9B37-4A2B-BBA2-FD5295390F3F Q36078783-6986916A-AFA8-4E61-BE83-2B3984B1342E Q36183088-5BAC7008-10D0-4331-98EC-26A72B7BCB74 Q36265006-E177B767-B9A1-4F8E-935C-D9B07CB15581 Q36414192-78322C87-B5C2-49FA-AB25-8F8074FE65E3 Q36934747-DC7C9397-D62F-456A-B7B8-1E9F2E13D59F Q37037419-2EEFA1FC-9486-40FD-B7D3-988427AEF33C Q37418853-7F874A36-3258-49CD-BE3C-0321B529AD9C Q37632051-AAD045B7-C70F-4223-B47C-96611734EF1B Q37878480-95B7E473-C706-4668-924A-A499B7165C13 Q37929754-2E98F466-1C8A-411B-AEA2-8A8146A48738 Q38040527-BBF17137-783B-4228-B038-BD855DE360E6 Q38584375-08E5A6DD-F60E-4907-8815-0935CF70AB33 Q39047435-705F6F5A-98DF-44A6-AABD-74D23FE54662 Q39095253-4558FDBD-7194-4C51-9517-83B42D7ECC8D Q42577186-49AC6354-4692-4435-BF2A-A28C4834A6B2 Q49347206-D5D1A61A-13DF-463D-A435-A99649A326DD Q51742865-AFBC5825-575E-4A39-ACF9-7D08A79344D2 Q54964676-699FD465-BEE5-49FD-BE7B-8D61935754C7

P2860

Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine

http://www.wikidata.org/entity/Q24629949

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Baseline meningococcal carriag ...... serogroup A conjugate vaccine

@ast

Baseline meningococcal carriag ...... serogroup A conjugate vaccine

@en

Baseline meningococcal carriag ...... serogroup A conjugate vaccine

@nl

type

label

Baseline meningococcal carriag ...... serogroup A conjugate vaccine

@ast

Baseline meningococcal carriag ...... serogroup A conjugate vaccine

@en

Baseline meningococcal carriag ...... serogroup A conjugate vaccine

@nl

prefLabel

Baseline meningococcal carriag ...... serogroup A conjugate vaccine

@ast

Baseline meningococcal carriag ...... serogroup A conjugate vaccine

@en

Baseline meningococcal carriag ...... serogroup A conjugate vaccine

@nl

P1433

Q24629949-000A5D52-9181-4E89-B4BA-F437D2B0A2D9

P1476

Q24629949-58D3C8DF-54C0-4473-B245-AEE5279CDA9B

P2093

Q24629949-117B163B-AFF4-480A-8164-CD6E52B851B0

Q24629949-1A5EC9AB-5D92-4485-A677-D20317725B30

Q24629949-1F1BD318-B1B6-4F0F-B4AD-48896714D7CC

Q24629949-415CE5F9-00AF-4C4D-B4D4-A1C5264F69FC

Q24629949-68F59D4D-E7B0-4D35-9EB2-A1EC957079DD

Q24629949-7458F93B-BA65-4BF2-AD09-3F4254C955B0

Q24629949-8193E796-2D17-465E-97BE-79ACDFCDFD48

Q24629949-A2D65BA5-89F0-4D36-BA3D-3E007388BEDA

Q24629949-C4F220B8-0301-4C0A-B608-2E52C2A2D3DF

Q24629949-C52A32FB-8A15-45E1-AD5F-F4D37A54EA83

P2860

Q24629949-0CA6604F-D54E-4429-81C0-B0BB6DAEBA8D

Q24629949-1E7EC097-1AC3-47EB-AE34-C33EB09DC7EA

Q24629949-252DDA00-FE12-4137-A262-09A109334385

Q24629949-305DE4FF-8ACE-408D-A2C3-796CD523D5CE

Q24629949-31B269C7-395C-4602-BD2B-FA26ECA9F5DB

Q24629949-341A1732-3044-4863-A4CE-93509DE9B0DD

Q24629949-46343B27-B880-4211-85CA-AEC4539982D5

Q24629949-6C9509FB-F2CF-4108-BB42-09A1D723DA92

Q24629949-7A293B76-B317-4A9B-9A99-72C5281F9094

Q24629949-80480B67-37F7-4248-B59B-907660FC5AB7

P304

Q24629949-1FF2FC17-8511-40EB-B8CF-BD32CC493404

P31

Q24629949-F1EFCEB7-D29B-4B22-A5F7-94A85DD708F8

P3181

Q24629949-8D93B7EA-5839-4474-AF28-068306FA14B0

P356

Q24629949-E7B3D451-A54F-4BEB-A23D-346F003B3767

P407

Q24629949-16063B4F-019E-4E93-A60E-DF93F95D77EA

P433

Q24629949-D546E8BF-7D0A-4C28-ACC2-B92CF549CBCC

P478

Q24629949-5C34BCD4-E74C-41DF-A2DB-46FD70A1A1A2

P50

Q24629949-C6BDC120-83CD-4959-B0C4-B2D628627493

Q24629949-D5278076-0130-41E6-9923-D43E5DCA9577

P577

Q24629949-0209FC7E-7B53-497E-9453-D64E2AA100F2

P698

Q24629949-0495E4E8-35F2-4217-82CC-71A9755AE6BD

P921

Q24629949-3B49541F-F0F3-4344-AB8A-BE0A8AFEE7DA

Q24629949-9916100C-0489-488F-A743-DB00E0BAA50D

P932

Q24629949-EA5AB55B-87DD-47EB-AFBB-A7F5C0B97EAC

P3181

P356

P1433

Clinical and Vaccine Immunology

P1476

Baseline meningococcal carriag ...... serogroup A conjugate vaccine

@en

P2093

Abdoul-Salam Ouédraogo

http://www.w3.org/2001/XMLSchema#string

Charles D Ouédraogo

http://www.w3.org/2001/XMLSchema#string

Cynthia Hatcher

http://www.w3.org/2001/XMLSchema#string

Denis Kandolo

http://www.w3.org/2001/XMLSchema#string

Dominique A Caugant

http://www.w3.org/2001/XMLSchema#string

Fabien Diomandé

http://www.w3.org/2001/XMLSchema#string

Idrissa Sanou

http://www.w3.org/2001/XMLSchema#string

Jennifer Dolan Thomas

http://www.w3.org/2001/XMLSchema#string

Ki Ba Absatou

http://www.w3.org/2001/XMLSchema#string

Mamoudou Djingarey

http://www.w3.org/2001/XMLSchema#string

P2860

CEREBROSPINAL MENINGITIS IN AFRICA

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

Meningococcal carriage and disease--population biology and evolution

Neisseria meningitidis: an overview of the carriage state

Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana.

Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway.

Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis.

Pharyngeal carriage of Neisseria meningitidis in 2-19-year-old individuals in Uganda.

Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine.

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis.

P304

435-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2670771

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/CVI.00479-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Lassana Sangaré

Nancy E. Messonnier

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21228139

http://www.w3.org/2001/XMLSchema#string

P921

clinical chemistry

P932

3067389

http://www.w3.org/2001/XMLSchema#string